Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.28% |
| Dec 31, 2025 | -7.94% |
| Sep 30, 2025 | -1.24% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | 18.72% |
| Dec 31, 2024 | -15.16% |
| Sep 30, 2024 | -11.08% |
| Jun 30, 2024 | 13.01% |
| Mar 31, 2024 | -6.84% |
| Dec 31, 2023 | 19.84% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | 2.57% |
| Mar 31, 2023 | 5.72% |
| Mar 31, 2022 | -17.04% |
| Dec 31, 2021 | -19.32% |
| Sep 30, 2021 | -16.05% |
| Jun 30, 2021 | 40.83% |
| Mar 31, 2021 | -46.65% |
| Dec 31, 2020 | 66.40% |
| Sep 30, 2020 | 61.79% |
| Jun 30, 2020 | -3.68% |
| Mar 31, 2020 | -37.84% |
| Dec 31, 2019 | 49.14% |
| Sep 30, 2019 | 21.00% |
| Jun 30, 2019 | -5.62% |
| Mar 31, 2019 | 2.17% |
| Dec 31, 2018 | -54.89% |
| Sep 30, 2018 | 1.02% |
| Jun 30, 2018 | 4.04% |
| Mar 31, 2018 | -4.17% |
| Dec 31, 2017 | -41.02% |
| Sep 30, 2017 | -11.08% |
| Jun 30, 2017 | -2.39% |
| Mar 31, 2017 | 8.18% |
| Dec 31, 2016 | 17.03% |
| Sep 30, 2016 | -2.91% |
| Jun 30, 2016 | -16.60% |
| Mar 31, 2016 | -12.25% |
| Dec 31, 2015 | -25.14% |
| Sep 30, 2015 | -34.98% |
| Jun 30, 2015 | -24.99% |
| Mar 31, 2015 | -3.59% |
| Dec 31, 2014 | -16.45% |
| Sep 30, 2014 | 2.90% |
| Jun 30, 2014 | -3.47% |
| Mar 31, 2014 | 1.80% |